Jazz Pharmaceuticals
JAZZ
#1410
Rank
S$19.08 B
Marketcap
S$297.39
Share price
-2.62%
Change (1 day)
29.19%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): S$0.33 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$4.71 Billion. In 2025 the company made an earning of -S$0.82 Billion a decrease over its 2024 earnings that were of S$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.33 B-141.75%
2025 -S$0.82 Billion-233.5%
2024 S$0.60 B57.87%
2023 S$0.38 B-179.92%
2022 -S$0.49 Billion230.37%
2021 -S$0.15 Billion-141.02%
2020 S$0.35 B-39.45%
2019 S$0.58 B-14.2%
2018 S$0.68 B20.03%
2017 S$0.56 B-17.15%
2016 S$0.68 B22.14%
2015 S$0.56 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.39 B73.63%
2012 S$0.22 B41.69%
2011 S$0.16 B116.61%
2010 S$74.63 M262.77%
2009 S$20.57 M-111.33%
2008 -S$0.19 Billion1.31%
2007 -S$0.18 Billion77.8%
2006 -S$0.11 Billion36.59%
2005 -S$73.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$16.32 B 4,766.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
S$2.70 B 707.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-S$3.09 Billion-1,020.78%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
S$1.58 B 371.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel